Medications to Avoid in Mobitz Type I Second-Degree Heart Block

Understanding Mobitz Type I AV Block

Mobitz type I (Wenckebach) second-degree AV block is characterized by progressive prolongation of the PR interval until a beat is not conducted, and the block is usually at the AV node level and is often transient and asymptomatic 1
It is commonly associated with inferior wall myocardial infarction and usually resolves spontaneously or after reperfusion 2
Unlike Mobitz type II block, Mobitz type I is generally benign and rarely progresses to complete heart block 1

Beta-blockers have negative dromotropic effects on the AV node and can prolong AV nodal conduction time, and should be used with caution in patients with pre-existing AV conduction abnormalities 3
Digoxin should be used with caution as it can further slow AV conduction, and if necessary, dose reduction and careful monitoring are required 3
Class I antiarrhythmic agents (flecainide, propafenone) should be avoided as they may worsen conduction disorders 3
Amiodarone should be used with caution due to its potential to cause bradycardia and AV block 3
Ivabradine is contraindicated in patients with second-degree AV block, and S1P receptor modulators (like ozanimod) should also be used with caution in Mobitz type I 4

If Mobitz type I AV block is symptomatic with hemodynamic compromise, atropine (0.5 mg IV every 3-5 minutes to maximum 3 mg) can be considered as first-line treatment, and doses of atropine less than 0.5 mg may paradoxically result in further slowing of heart rate 1, 5, 6
If medication-induced Mobitz type I block occurs, the offending agent should be discontinued 2, 7
Temporary pacing may be indicated for medically refractory symptomatic or hemodynamically significant bradycardia, and permanent pacing is generally not indicated for Mobitz type I AV block unless it is symptomatic and does not respond to medication discontinuation 5
In the context of acute MI, Mobitz type I block is usually transient and resolves spontaneously or with reperfusion 2

The European Society of Cardiology recommends that digoxin should be avoided as it can further slow AV conduction and potentially worsen the block 8
The American Heart Association suggests that combination therapy with multiple AV nodal blocking agents (e.g., beta-blocker plus calcium channel blocker) carries particularly high risk of worsening AV block 9
The American College of Cardiology advises that amiodarone should be used with extreme caution due to its potential to cause bradycardia and worsen AV block 10
The American Heart Association recommends that tricyclic antidepressants should be used with caution as they can cause PR and QRS prolongation 10
The American Psychiatric Association suggests that certain antipsychotic medications (thioridazine, haloperidol) that prolong QT interval should be avoided 10